Basiliximab, sold under the brand name Simulect, is a monoclonal antibody used to prevent rejection in kidney transplants. It is a chimeric mouse-human monoclonal antibody to the α chain of the IL-2 receptor of T cells. From Wikipedia
Whistleblowers allege unauthorized drug use and lack of informed consent in clinical practices linked to a patient death and health deterioration in others.
